Roi Tschernichovsky

Rehovot, M, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Two-year toxicity and PSA dynamics in the initial cohort of the SABR-Dual trial - two-fraction stereotactic radiotherapy for localized prostate cancer using rectal spacing.

Two-year toxicity and PSA dynamics in the initial cohort of the SABR-Dual trial - two-fraction stereotactic radiotherapy for localized prostate cancer using rectal spacing.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 04, 2026

Use and Overuse of Positron Emission Tomography for Patients with Metastatic Colorectal Cancer.

Use and Overuse of Positron Emission Tomography for Patients with Metastatic Colorectal Cancer.

Journal: The oncologist

Published: September 27, 2025

Stereotactic Radiotherapy to the Prostate and Pelvic Lymph Nodes for High-Risk and Very High-Risk Prostate Cancer in a Setting with a Hydrogel Spacer: A Toxicity Report.

Stereotactic Radiotherapy to the Prostate and Pelvic Lymph Nodes for High-Risk and Very High-Risk Prostate Cancer in a Setting with a Hydrogel Spacer: A Toxicity Report.

Journal: Cancers

Published: May 15, 2025

Emerging clinical applications of single-cell RNA sequencing in oncology.

Emerging clinical applications of single-cell RNA sequencing in oncology.

Journal: Nature reviews. Clinical oncology

Published: February 11, 2025

A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor.

A phase II, open-label, single-arm trial of pembrolizumab for recurrent meningioma and solitary fibrous tumor.

Journal: Neuro-oncology advances

Published: October 21, 2024

The impact of brain MRI screening on stage IV NSCLC patients: A real world look at guidelines based care.

The impact of brain MRI screening on stage IV NSCLC patients: A real world look at guidelines based care.

Journal: Journal of the neurological sciences

Published: July 09, 2024

Acute Toxicity and Early Prostate Specific Antigen Response After Two-Fraction Stereotactic Radiation Therapy for Localized Prostate Cancer Using Peri-Rectal Spacing-Initial Report of the SABR-Dual Trial.

Acute Toxicity and Early Prostate Specific Antigen Response After Two-Fraction Stereotactic Radiation Therapy for Localized Prostate Cancer Using Peri-Rectal Spacing-Initial Report of the SABR-Dual Trial.

Journal: International journal of radiation oncology, biology, physics

Published: April 18, 2024

Choosing Wisely in oncology: are guidelines effective at preventing unnecessary diagnostics? The example of surveillance positron emission tomography for patients with localised colorectal cancer.

Choosing Wisely in oncology: are guidelines effective at preventing unnecessary diagnostics? The example of surveillance positron emission tomography for patients with localised colorectal cancer.

Journal: BMJ oncology

Published: March 06, 2024

The Curated Cancer Cell Atlas provides a comprehensive characterization of tumors at single-cell resolution.

The Curated Cancer Cell Atlas provides a comprehensive characterization of tumors at single-cell resolution.

Journal: Nature cancer

Published: January 19, 2024

Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment.

Converging survival trends in non-small cell lung cancer patients with and without brain metastasis receiving state-of-the-art treatment.

Journal: Journal of neuro-oncology

Published: December 09, 2023

Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature.

Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature.

Journal: Thoracic cancer

Published: February 07, 2023

Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer.

Driver mutation characteristics of phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) in advanced non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 16, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026